MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
| hmdb:HMDB0056486 DVZBPYOCQGSXKO-QJONVJLHSA-N | CL(16:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (2S)-3-{[(2R)-2,3-bis(hexadecanoyloxy)propoxy(hydroxy)phosphoryl]oxy}-2-hydroxypropoxy((2R)-2,3-bis[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]propoxy)phosphinic acid 1'-[1,2-Dihexadecanoyl-rac-glycero-3-phospho],3'-[1,2-di(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-rac-glycero-3-phospho]-glycerol 1'-[1,2-Dipalmitoyl-rac-glycero-3-phospho],3'-[1,2-didocosahexaenoyl-rac-glycero-3-phospho]-glycerol CL(1'-[16:0/16:0],3'-[22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)]) CL(16:0/16:0/22:6/22:6) CL(76:12) Cardiolipin(16:0/16:0/22:6/22:6) Cardiolipin(76:12) [(2S)-3-({[(2R)-2,3-bis(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy][(2R)-2,3-bis[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]propoxy]phosphinic acid |
SLM:000513796 slm:000513796 DVZBPYOCQGSXKO-OXKFMQDVSA-L | Cardiolipin (16:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 1'-[1,2-di-hexadecanoyl-sn-glycero-3-phospho],3'-[1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho]-glycerol CL (16:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
hmdb:HMDB56486 | secondary/obsolete/fantasy identifier |